Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4538.T Stock Summary
Top 10 Correlated ETFs
4538.T
In the News
4538.T Financial details
Company Rating
Buy
Market Cap
20.35B
Income
1.34B
Revenue
54.63B
Book val./share
4263.41
Cash/share
789.18
Dividend
75
Dividend %
3.8%
Employees
1.37K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
13.28
Forward P/E
-
PEG
-15.98
P/S
0.31
P/B
0.48
P/C
2.79
P/FCF
-
Quick Ratio
1.02
Current Ratio
1.49
Debt / Equity
0.4
LT Debt / Equity
0.22
-
-
EPS (TTM)
155.04
EPS next Y
-
EPS next Q
-
EPS this Y
8.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.44%
Revenue last 5Y
2.06%
Revenue Q/Q
10.7%
EPS Q/Q
120.85%
-
-
-
-
SMA20
2.77%
SMA50
13.71%
SMA100
18.87%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.04%
Gross Margin
26%
Oper. Margin
4%
Profit Margin
2%
Payout
-
Shs Outstand
9.22M
Shs Float
5.61M
-
-
-
-
Target Price
-
52W Range
1841.0-2350.0
52W High
-6.38%
52W Low
+19.5%
RSI
39.94
Rel Volume
0.26
Avg Volume
30.58K
Volume
8.1K
Perf Week
-5.46%
Perf Month
3%
Perf Quarter
11.62%
Perf Half Y
9.51%
-
-
-
-
Beta
0.3
-
-
Volatility
66.55%, 55.75%
Prev Close
0.82%
Price
2200
Change
-5.34%
4538.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.25K | 5.34K | 5.61K | 5.66K | 5.82K | |
Net income per share | 101.86 | 80.57 | 183.16 | 169.05 | 182.99 | |
Operating cash flow per share | 233.68 | 652.54 | 368.15 | 398.75 | 325.27 | |
Free cash flow per share | -30.42 | 367.41 | 230.24 | 229.24 | 145.82 | |
Cash per share | 633.83 | 810.49 | 788.84 | 821.44 | 896.47 | |
Book value per share | 3.74K | 3.68K | 3.84K | 3.94K | 4.06K | |
Tangible book value per share | 3.66K | 3.62K | 3.8K | 3.88K | 4.03K | |
Share holders equity per share | 3.74K | 3.68K | 3.84K | 3.94K | 4.06K | |
Interest debt per share | 1.96K | 1.75K | 1.53K | 1.4K | 1.46K | |
Market cap | 22.67B | 18.37B | 22.33B | 19.18B | 17.51B | |
Enterprise value | 33.94B | 26.19B | 28.45B | 23.92B | 22.13B | |
P/E ratio | 25.36 | 25.98 | 13.89 | 12.93 | 10.91 | |
Price to sales ratio | 0.49 | 0.39 | 0.45 | 0.39 | 0.34 | |
POCF ratio | 11.05 | 3.21 | 6.91 | 5.48 | 6.14 | |
PFCF ratio | -84.91 | 5.7 | 11.05 | 9.54 | 13.69 | |
P/B Ratio | 0.69 | 0.57 | 0.66 | 0.56 | 0.49 | |
PTB ratio | 0.69 | 0.57 | 0.66 | 0.56 | 0.49 | |
EV to sales | 0.74 | 0.56 | 0.58 | 0.48 | 0.43 | |
Enterprise value over EBITDA | 9.85 | 7.27 | 5.88 | 5.19 | 4.66 | |
EV to operating cash flow | 16.55 | 4.57 | 8.81 | 6.84 | 7.76 | |
EV to free cash flow | -127.13 | 8.12 | 14.09 | 11.9 | 17.3 | |
Earnings yield | 0.04 | 0.04 | 0.07 | 0.08 | 0.09 | |
Free cash flow yield | -0.01 | 0.18 | 0.09 | 0.1 | 0.07 | |
Debt to equity | 0.52 | 0.47 | 0.39 | 0.35 | 0.35 | |
Debt to assets | 0.24 | 0.22 | 0.19 | 0.17 | 0.17 | |
Net debt to EBITDA | 3.27 | 2.17 | 1.26 | 1.03 | 0.97 | |
Current ratio | 1.45 | 1.48 | 1.48 | 1.51 | 1.52 | |
Interest coverage | 5.58 | 4.51 | 11.99 | 10.93 | 13.37 | |
Income quality | 1.63 | 5.5 | 1.38 | 1.83 | 1.29 | |
Dividend Yield | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.78 | 0.87 | 0.33 | 0.35 | 0.33 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | -1.13 | -0.44 | -0.37 | -0.43 | -0.55 | |
Capex to revenue | -0.05 | -0.05 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -1.18 | -1.05 | -0.5 | -0.58 | -0.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.93K | 2.58K | 3.98K | 3.87K | 4.09K | |
ROIC | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Graham Net | -1.31K | -1.06K | -879.51 | -719.56 | -694.44 | |
Working capital | 11.96B | 12.31B | 12.77B | 13.41B | 14.75B | |
Tangible asset value | 32.09B | 31.78B | 33.36B | 34.08B | 35.32B | |
Net current asset value | -457M | 1.16B | 3.34B | 4.98B | 6.4B | |
Invested capital | 0.52 | 0.47 | 0.39 | 0.35 | 0.35 | |
Average receivables | 22.43B | 21.43B | 21.11B | 21.48B | 21.78B | |
Average payables | 8.97B | 9.4B | 8.27B | 6.51B | 6.07B | |
Average inventory | 9.96B | 10.15B | 10.37B | 10.62B | 11.48B | |
Days sales outstanding | 176.19 | 160.49 | 160 | 157.18 | 158.72 | |
Days payables outstanding | 102.43 | 103.12 | 71.82 | 61.44 | 59.19 | |
Days of inventory on hand | 115.08 | 107.15 | 111.39 | 105.87 | 121.91 | |
Receivables turnover | 2.07 | 2.27 | 2.28 | 2.32 | 2.3 | |
Payables turnover | 3.56 | 3.54 | 5.08 | 5.94 | 6.17 | |
Inventory turnover | 3.17 | 3.41 | 3.28 | 3.45 | 2.99 | |
ROE | 0.03 | 0.02 | 0.05 | 0.04 | 0.05 | |
Capex per share | -264.11 | -285.13 | -137.91 | -169.51 | -179.45 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.58K | 1.34K | 1.54K | 1.6K | 1.82K | |
Net income per share | 54.23 | 12.77 | 54.62 | 27.29 | 60.27 | |
Operating cash flow per share | 144.31 | 124.28 | 122.92 | 124.07 | 132.12 | |
Free cash flow per share | 144.31 | 124.28 | 122.92 | 124.07 | 132.12 | |
Cash per share | 930.28 | 896.52 | 921.44 | 862.5 | 789.18 | |
Book value per share | 4.06K | 4.06K | 4.11K | 4.11K | 4.26K | |
Tangible book value per share | 4.06K | 4.03K | 4.11K | 4.11K | 4.26K | |
Share holders equity per share | 4.06K | 4.06K | 4.11K | 4.11K | 4.26K | |
Interest debt per share | 1.44K | 1.44K | 1.38K | 1.57K | 1.69K | |
Market cap | 17.5B | 17.51B | 17.59B | 17.19B | 16B | |
Enterprise value | 21.92B | 22.12B | 21.59B | 23.35B | 23.6B | |
P/E ratio | 9.21 | 39.08 | 9.18 | 18.06 | 7.84 | |
Price to sales ratio | 1.26 | 1.48 | 1.3 | 1.24 | 1.04 | |
POCF ratio | 13.84 | 16.06 | 16.32 | 15.89 | 14.31 | |
PFCF ratio | 13.84 | 16.06 | 16.32 | 15.89 | 14.31 | |
P/B Ratio | 0.49 | 0.49 | 0.49 | 0.48 | 0.44 | |
PTB ratio | 0.49 | 0.49 | 0.49 | 0.48 | 0.44 | |
EV to sales | 1.58 | 1.88 | 1.6 | 1.68 | 1.53 | |
Enterprise value over EBITDA | 30.03 | 101.02 | 33.53 | 46.05 | 18.13 | |
EV to operating cash flow | 17.34 | 20.3 | 20.03 | 21.58 | 21.11 | |
EV to free cash flow | 17.34 | 20.3 | 20.03 | 21.58 | 21.11 | |
Earnings yield | 0.03 | 0.01 | 0.03 | 0.01 | 0.03 | |
Free cash flow yield | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 | |
Debt to equity | 0.35 | 0.35 | 0.34 | 0.38 | 0.4 | |
Debt to assets | 0.17 | 0.17 | 0.16 | 0.18 | 0.18 | |
Net debt to EBITDA | 6.06 | 21.09 | 6.21 | 12.15 | 5.84 | |
Current ratio | 1.53 | 1.52 | 1.5 | 1.49 | 1.52 | |
Interest coverage | 15.81 | 6.03 | 15.5 | 11.86 | 16.15 | |
Income quality | 2.66 | 9.73 | 2.25 | 4.55 | 2.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.23K | 1.08K | 2.25K | 1.59K | 2.4K | |
ROIC | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Graham Net | -686.55 | -694.48 | -795.32 | -951.97 | -1.02K | |
Working capital | 15.33B | 14.75B | 15.05B | 15.15B | 16.15B | |
Tangible asset value | 35.22B | 35.32B | 35.68B | 35.44B | 35.63B | |
Net current asset value | 6.61B | 6.4B | 6.47B | 5.47B | 5.73B | |
Invested capital | 0.35 | 0.35 | 0.34 | 0.38 | 0.4 | |
Average receivables | 22.55B | 22.79B | 22.48B | 23.32B | 25.07B | |
Average payables | 6.36B | 6.49B | 6.5B | 7.19B | 12.15B | |
Average inventory | 11.38B | 11.95B | 12.83B | 13.28B | 13.28B | |
Days sales outstanding | 152.02 | 169.26 | 151.79 | 154.35 | 153.52 | |
Days payables outstanding | 60.89 | 62.64 | 62.59 | 63.38 | 131.13 | |
Days of inventory on hand | 100.39 | 129 | 118.85 | 113.93 | 102.72 | |
Receivables turnover | 0.59 | 0.53 | 0.59 | 0.58 | 0.59 | |
Payables turnover | 1.48 | 1.44 | 1.44 | 1.42 | 0.69 | |
Inventory turnover | 0.9 | 0.7 | 0.76 | 0.79 | 0.88 | |
ROE | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
4538.T Frequently Asked Questions
What is Fuso Pharmaceutical Industries,Ltd. stock symbol ?
Fuso Pharmaceutical Industries,Ltd. is a JP stock and trading under the symbol 4538.T
What is Fuso Pharmaceutical Industries,Ltd. stock quote today ?
Fuso Pharmaceutical Industries,Ltd. stock price is $2200 today.
Is Fuso Pharmaceutical Industries,Ltd. stock public?
Yes, Fuso Pharmaceutical Industries,Ltd. is a publicly traded company.